NRXS
Neuraxis, INC
NASDAQ · Healthcare · Biotechnology · US
$6.86
+4.26%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 21.42x
- P/S forward
- 5.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 12.79x
- Price / sales
- 16.20x
- Price / cash flow
- -15.33x
Enterprise value
- Enterprise value
- $78.1M
- EV / sales
- 14.69x
- EV / EBITDA
- -10.41x
- EV / EBIT
- -10.17x
- Market cap
- $86.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026